GFAP and myeloid sarcoma: In progressive MS, GFAP levels strongly correlated with CD14+ monocyte frequency and, to a lesser extent, with T cells, consistent with potential involvement of myeloid cells in neurodegeneration, though causal relationships remain to be established and may be influenced by age-related processes.